CONTROL OF INTRAOCULAR PRESSURE USING ALK5 MODULATION AGENTS
An ophthalmic pharmaceutical composition useful in the treatment of glaucoma and control of intraocular pressure comprising an effective amount of a selective modulator of ALK5 receptor activity is disclosed. Also disclosed is a method of treating glaucoma and controlling intraocular pressure compri...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.06.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!